Securities and Exchange Commission

Effective Income Tax Rate Reconciliation, Deduction, Percent

Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.

Compare To Other Companies

Annual (pure)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
0	2021-07-09	10-K	2020	FY	2019-01-01	2019-12-31	CY2019
0.002	2022-03-31	10-K	2021	FY	2020-01-01	2020-12-31	CY2020
0.003	2023-03-31	10-K	2022	FY	2021-01-01	2021-12-31	CY2021
0.024	2024-03-25	10-K	2023	FY	2022-01-01	2022-12-31	CY2022
0.106	2025-03-31	10-K	2024	FY	2023-01-01	2023-12-31	CY2023
0.05	2025-03-31	10-K	2024	FY	2024-01-01	2024-12-31	CY2024

All Reported Effective Income Tax Rate Reconciliation, Deduction, Percent (pure)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
0.21	2018-03-29	10-K	2017	FY	2017-12-01	2017-12-22
0.21	2019-04-01	10-K	2018	FY	2017-12-01	2017-12-22	CY2017Q4I
0	2021-07-09	10-K	2020	FY	2019-01-01	2019-12-31	CY2019
0.002	2021-07-09	10-K	2020	FY	2020-01-01	2020-12-31
0.002	2022-03-31	10-K	2021	FY	2020-01-01	2020-12-31	CY2020
0.003	2022-03-31	10-K	2021	FY	2021-01-01	2021-12-31
0.003	2023-03-31	10-K	2022	FY	2021-01-01	2021-12-31	CY2021
0.024	2023-03-31	10-K	2022	FY	2022-01-01	2022-12-31
0.024	2024-03-25	10-K	2023	FY	2022-01-01	2022-12-31	CY2022
0.106	2024-03-25	10-K	2023	FY	2023-01-01	2023-12-31
0.106	2025-03-31	10-K	2024	FY	2023-01-01	2023-12-31	CY2023
0.05	2025-03-31	10-K	2024	FY	2024-01-01	2024-12-31	CY2024